OCT CRO provides end-to-end drug registration and clinical trial support in Russia and the Eurasian Economic Union (EAEU) countries. We help pharmaceutical and biotech companies enter new, fast-growing markets by navigating complex regulatory pathways and local requirements.
Book a consultation
The EAEU is a single regulatory space for pharmaceuticals, offering drugs access to EAEU countries' market faster and simplified through one coordinated framework.
OCT provides a full range of services for the marketing authorization of medicines in Russia and EAEU countries, for both local and International Sponsors.
Steps 1-3: 11 months-1.5 year (140 working days expertise + stop times for applicant's replies)
Step 4: ≈ 8 months
(100 working days expertise+
stop times for applicant's replies)
OCT CRO supports sponsors at every stage of this process.
Book a consultation
Whether you are planning your first registration or expanding an existing portfolio, OCT CRO will guide you every step of the way.
Contact us for a consultation: info@oct-cro.com